fbpx

Melanoma Diagnosis? Use Every Therapy At Your Disposal-

Share Button

“However, once melanoma spreads, there is still basically no effective treatment at this point.” Therefore early detection is key

The solution then is to reduce your risk of skin cancer. Make no mistake. Skin cancer is complicated.

Click the image below to enlarge-

Skin Cancer Mind Map

As you can see from the illustration to the left, melanoma risks, therapies, etc. are complicated as well.

Surviving a different incurable cancer since 1994 has taught me that patients diagnosed with aggressive cancers must rely on both conventional (FDA approved) and evidence-based, non-conventional therapies to manage their cancer.

Nutrition, supplementation, bone health, detoxification- all evidence-based therapies that research shows can kill your cancer.

 

Have you been diagnosed with melanoma? Has your melanoma spread or become metastatic? Scroll down the page, post a question or comment and I will reply to you ASAP.

Thanks,

David Emerson

  • Cancer Survivor
  • Cancer Coach
  • Director PeopleBeatingCancer

New vistas in skin cancer care

” “However, once melanoma spreads, there is still basically no effective treatment at this point.””

MyPath (Myriad Genetics Inc.) is a genetic test that was recently released to profile 23 genes.

“The degree of expression of these genes helps to differentiate whether the lesion is melanoma or benign,” Dr. Rigel says.

Dr. Rigel notes that use of the myPath test is increasing because it allows pathologists to make a more definite diagnosis of melanoma in equivocal lesions.

Class I is low risk for metastatic disease, while Class II is high risk.

Similarly, nivolumab and pembrolizumab are two drugs in a new class of biologics that blocks programmed cell death protein 1 (PD-1).

“What is particularly exciting about this class of drugs is that after three years of use, the mortality curves appear to flatten, suggesting that we may be approaching a ‘cure’ for those surviving this therapy,” Dr. Rigel says…”

Leave a Comment: